The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
about
Evidence for the role of corticotropin-releasing factor in major depressive disorderInnovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.Bipolar disorder: candidate drug targets.Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsRole of CRF receptor signaling in stress vulnerability, anxiety, and depression.Progress in corticotropin-releasing factor-1 antagonist development.A final common pathway for depression? Progress toward a general conceptual framework.Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in ratsSelectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinityStress-induced potentiation of cocaine reward: a role for CRF R1 and CREB.Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factorTransient gastric irritation in the neonatal rats leads to changes in hypothalamic CRF expression, depression- and anxiety-like behavior as adults.Treatment with CRH-1 antagonist antalarmin reduces behavioral and endocrine responses to social stressors in marmosets (Callithrix kuhlii).Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileumDepressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor.[(76) Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor.A final common pathway for depression: implications for therapy.A corticotropin-releasing factor receptor antagonist improves urodynamic dysfunction produced by social stress or partial bladder outlet obstruction in male rats.Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity.Innovations in CNS drug discovery: differentiating strategies to treat depression.Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm.Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression.Essential Role of Ovarian Hormones in Susceptibility to the Consequences of Witnessing Social Defeat in Female Rats.
P2860
Q26798878-34514C7D-D8D6-45A4-A322-0BEE62362073Q26996411-D39EBBC0-6082-4A32-99EB-5C3074E0057BQ27014879-0C5A734F-30E8-4DAA-9BE0-62945125AAF1Q28751133-C7CB64BA-ABB4-4AAB-AD51-60B3685D5652Q30465636-A6572A8A-CF14-457B-982D-D8F968C2D0F5Q30466695-6E46DE7A-3482-41B8-A0F9-EE1AE566EE9FQ30475129-F045175C-8FF8-4A06-AABC-4D6A19248347Q30475627-ABCFC097-F0FC-4AE1-BA98-EF9EF551DF49Q30491982-138E846F-F089-43D7-9470-D3DDBE7CA112Q33153854-3E7E2AC2-9BFB-4452-8A42-C0B91B3EA34CQ33662388-48B9993D-171E-4A6A-88AD-CE5175CDFBAAQ33665169-DD7F10DD-B1CB-4F5E-9E2B-D34832E72688Q33772332-48D841CD-DAD7-41B9-BBBA-6A7405DA789FQ33903930-A1376D01-15CF-498C-BB43-1A8C2420FFAEQ34330259-D5D41F82-5477-406A-935C-583448546264Q35879842-11B7A5E2-CF5F-49DC-99B1-C9A4B41A38B2Q36731712-19F48881-F621-41AC-B853-F1BC55DD45DBQ36764636-47D663C3-2D47-491A-AAD3-8A34C08E2EE0Q36897335-BBD5F481-85C4-456B-B649-774716D6523DQ36923889-E6FC9EB2-9927-4588-883E-FC8578E4E76EQ37357463-5A5D141E-25BD-4D76-8CFC-F709606D9DD9Q37720094-69A58F09-E2A2-4E98-AFB9-22879AC2889EQ38088733-3FDC4EEA-04EC-4508-A1F5-69B82889A0BDQ44518261-E20DC08A-1363-4BD6-8F38-084C9676F8F3Q45934195-084F3CE1-D9B1-43D8-86FD-F3935E7C399AQ53433266-BD0D4A46-EE1A-494E-A870-B46BC69C9D17
P2860
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@ast
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@en
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@nl
type
label
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@ast
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@en
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@nl
prefLabel
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@ast
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@en
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@nl
P2093
P2860
P1433
P1476
The effects of CRF antagonists ...... in adrenocorticotropin in rats
@en
P2093
Emily M Jutkiewicz
Hani Houshyar
James H Woods
Kenner C Rice
P2860
P2888
P304
P356
10.1007/S00213-005-2164-Z
P577
2005-02-05T00:00:00Z
P5875
P6179
1005893090